首页> 外文期刊>International Journal of Cardiology >Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.
【24h】

Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial.

机译:强化与标准他汀类药物治疗对急性心肌梗死患者内皮祖细胞和左心室功能的影响:他汀类药物可在急性心肌梗死和PCI(STRAP)试验后再生。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Intensive statin therapy can lower the risk of recurrence of major cardiac events in patients with acute coronary syndromes. This could be related to the ability of statins to increase levels of Endothelial Progenitor Cells (EPCs), which were demonstrated to be favorably associated with a better prognosis and post-infarction left ventricular remodeling in patients with ischemic heart disease. AIM OF THE STUDY: First, to evaluate, in a randomized clinical trial, the effect of an intensive vs a standard treatment with statins on EPC mobilization in patients undergoing a successful primary or rescue percutaneous coronary intervention; secondary, to evaluate whether left ventricular remodeling could be influenced by statin therapy through EPC mobilization. METHODS: Forty ST-segment elevation myocardial infarction (STEMI) patients undergoing a successful primary or rescue PCI were randomized to receive atorvastatin 80 mg immediately after the admission (Intensive Treatment, IT) or atorvastatin 20 mg from the day of the discharge (Standard Treatment, ST). CD34+/KDR+ EPC count by flow cytometry and left ventricular function by 2-D Echo were measured on admission, at discharge and at 4 months follow up. RESULTS: We found that EPC count was similar in the two groups of patients both on admission and at discharge. At follow up, however, EPC count was higher in patients randomized to IT compared to patients randomized to ST (7.59+/-7.30 vs 3.04+/-3.93, p=0.04). However, LV volumes, ejection fraction and wall motion score index were similar in both groups. CONCLUSIONS: An intensive statin treatment after primary or rescue PCI is associated with a higher EPC count at follow up as compared to standard treatment. This beneficial effect did not translate in an improvement of LV function.
机译:背景:他汀类药物强化治疗可以降低急性冠脉综合征患者发生重大心脏事件的风险。这可能与他汀类药物增加内皮祖细胞(EPC)水平的能力有关,事实证明,他汀与缺血性心脏病患者的更好预后和梗死后左心室重构密切相关。研究的目的:首先,在一项随机临床试验中,对接受成功的经皮冠状动脉介入治疗或急诊经皮冠状动脉介入治疗的患者,评估他汀类药物强化治疗与标准治疗对EPC动员的影响;其次,评估通过EPC动员他汀治疗是否会影响左心室重塑。方法:将四十名接受成功的原发性或抢救性PCI治疗的ST段抬高型心肌梗死(STEMI)患者随机入院(强化治疗,IT)后立即接受阿托伐他汀80 mg或自出院之日起20 mg阿托伐他汀(标准治疗) ,ST)。在入院时,出院时和随访4个月时,通过流式细胞术检测CD34 + / KDR + EPC计数,并通过2-D Echo检测左心室功能。结果:我们发现两组患者入院时和出院时的EPC计数均相似。然而,在随访中,随机分配至IT的患者的EPC计数高于随机分配至ST的患者(7.59 +/- 7.30 vs 3.04 +/- 3.93,p = 0.04)。然而,两组的左室容积,射血分数和壁运动评分指数相似。结论:与标准治疗相比,在初次或急诊PCI后进行强化他汀类药物治疗与随访时较高的EPC计数有关。该有益效果并未转化为LV功能的改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号